Skin Cancer

An effective treatment plan for squamous cell carcinoma best undertaken by a group of practitioners.

A study assessing melanoma cell variability indicates that identifying differences in cell states can be leveraged to improve patient outcomes.

Study suggests that blocking a signaling pathway that includes the inflammatory factor CXCL10-CXCR3 may prevent brain metastasis.

Research highlights the importance of reaching non-white and younger populations with skin cancer prevention messages.

A new message by the Public Access to SunScreens (PASS) Coalition—comprised of public health organizations, physician groups, sunscreen manufacturers, and citizens—emphasizes the importance of sunscreen in reducing the risk of melanoma, other skin cancers, and premature aging.1

Investigators find visuals more effective than language when prompting people to self-screen for melanoma.

With summer a month away, patients are likely to ask for advice on preventing and recognizing the disease.

Pharmacists can counsel patients on the best ways to reduce the risk of skin cancer.

Eighty-three percent of physicians excising more-than-necessary amounts of tissue on a regular basis during Mohs micrographic surgery.

The combination therapy reduced the risk of squamous cell carcinoma development on the face and scalp by approximately 75% in the study.

A simple, compact laser probe is an opportunity for early detection of melanoma, the deadliest form of skin cancer.

Skin cancer remains the most common form of cancer in the United States, with more than 65,000 cases of melanoma estimated in 2011, according to the CDC.

Azathioprine, a drug used to treat a variety of conditions, may contribute to skin cancer development.

Study identifies a potential association between azathioprine and the mutational signature found in cases of cutaneous squamous cell carcinoma.

Undertreated side effects in treatment of some colon and stomach cancers need to be addressed.

Highest uninsured rates found in patients with testicular, stomach, and cervical cancers.

Treatment found to cause a delay in tumor growth during clinical trials.